CCL2 and COVID-19: Li et al. indicated the increased levels of many inflammatory mediators in the cerebrospinal fluid, including IL-6, IL-8, MCP-1, and granulocyte-macrophage colony-stimulating factor (GM-CSF) in COVID-19 patients (Li et al., 2016).